Nutritional management of people living with cystic fibrosis throughout life and disease continuum: Changing times, new challenges

被引:4
作者
Mailhot, Genevieve [1 ,2 ,5 ]
Denis, Marie-Helene [3 ]
Beauchamp-Parent, Caroline [1 ]
Jomphe, Valerie [4 ]
机构
[1] Fac Med, Dept Nutr, Montreal, PQ, Canada
[2] CHU Sainte Justine, Res Ctr, Montreal, PQ, Canada
[3] CHU Sainte Justine, Cyst Fibrosis Clin, Montreal, PQ, Canada
[4] Ctr Hosp Univ Montreal CHUM, Lung Transplant Program, Montreal, PQ, Canada
[5] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3T 1A8, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
CFTR modulators; cystic fibrosis; life stages; nutrition; CLINICAL-PRACTICE GUIDELINES; ABNORMAL GLUCOSE-TOLERANCE; LONG-TERM SAFETY; EATING-DISORDERS; LUNG-FUNCTION; OPEN-LABEL; SODIUM DEFICIT; MECONIUM ILEUS; YOUNG-ADULTS; WEIGHT-GAIN;
D O I
10.1111/jhn.13214
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding for the ion channel cystic fibrosis transmembrane conductance regulator (CFTR). The management of CF disease has evolved in recent decades from treating downstream disease manifestations affecting the airways, the lungs and the gastrointestinal system to addressing the CFTR gene defect. The advent of CFTR modulators, which correct the functionality of the defective CFTR, contributes to reshaping the landscape of CF demographics, prognosis and therapies, including nutritional management. A spectrum of clinical manifestations is emerging within the same patient population where undernutrition and nutritional deficiencies coexist with excessive weight gain and metabolic derangements. Such contrasting presentations challenge current practices, require adjustments to traditional approaches, and involve more individualised interventions. This narrative review examines the current state of knowledge on the nutritional management of people living with cystic fibrosis from early life to adulthood in the era of CFTR modulation.
引用
收藏
页码:1675 / 1691
页数:17
相关论文
共 158 条
[61]   Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial [J].
Heijerman, Harry G. M. ;
McKone, Edward F. ;
Downey, Damian G. ;
Van Braeckel, Eva ;
Rowe, Steven M. ;
Tullis, Elizabeth ;
Mall, Marcus A. ;
Welter, John J. ;
Ramsey, Bonnie W. ;
Mckee, Charlotte M. ;
Marigowda, Gautham ;
Moskowitz, Samuel M. ;
Waltz, David ;
Sosnay, Patrick R. ;
Simard, Christopher ;
Ahluwalia, Neil ;
Xuan, Fengjuan ;
Zhang, Yaohua ;
Taylor-Cousar, Jennifer L. ;
Mccoy, Karen S. .
LANCET, 2019, 394 (10212) :1940-1948
[62]   Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study [J].
Hoppe, Jordana E. ;
Chilvers, Mark ;
Ratjen, Felix ;
McNamara, John J. ;
Owen, Caroline A. ;
Tian, Simon ;
Zahigian, Rachel ;
Cornell, Alexandra G. ;
McColley, Susanna A. .
LANCET RESPIRATORY MEDICINE, 2021, 9 (09) :977-988
[63]   Primary resection and anastomosis for complicated meconium ileus: a safe procedure? [J].
Jawaheer, Jhalini ;
Khalil, Basem ;
Plummer, Tyasha ;
Bianchi, Adrian ;
Morecroft, James ;
Rakoczy, George ;
Bruce, James ;
Bowen, John ;
Morabito, Antonino .
PEDIATRIC SURGERY INTERNATIONAL, 2007, 23 (11) :1091-1093
[64]   Cystic fibrosis related diabetes: Nutrition and growth considerations [J].
Kaminski, Beth A. ;
Goldsweig, Bracha K. ;
Sidhaye, Aniket ;
Blackman, Scott M. ;
Schindler, Teresa ;
Moran, Antoinette .
JOURNAL OF CYSTIC FIBROSIS, 2019, 18 :S32-S37
[65]   Issues in the management of simple and complex meconium ileus [J].
Karimi, A. ;
Gorter, R. R. ;
Sleeboom, Chr ;
Kneepkens, C. M. F. ;
Heij, H. A. .
PEDIATRIC SURGERY INTERNATIONAL, 2011, 27 (09) :963-968
[66]   Deficits in Bone Mineral Content in Children and Adolescents With Cystic Fibrosis Are Related to Height Deficits [J].
Kelly, Andrea ;
Schall, Joan I. ;
Stallings, Virginia A. ;
Zemel, Babette S. .
JOURNAL OF CLINICAL DENSITOMETRY, 2008, 11 (04) :581-589
[67]   Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension [J].
King, Susannah J. ;
Tierney, Audrey C. ;
Edgeworth, Deirdre ;
Keating, Dominic ;
Williams, Elyssa ;
Kotsimbos, Tom ;
Button, Brenda M. ;
Wilson, John W. .
NUTRITION, 2021, 85
[68]   BMI fails to identify poor nutritional status in stunted children with CF [J].
Konstan, Michael W. ;
Pasta, David J. ;
Wagener, Jeffrey S. ;
VanDevanter, Donald R. ;
Morgan, Wayne J. .
JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (01) :158-160
[69]   Delayed Presentation of Meconium Ileus in an Infant With Cystic Fibrosis [J].
Lahiri, Thomas ;
Sullivan, Jillian S. ;
Sartorelli, Kennith H. ;
Murphy, James J. .
PEDIATRICS, 2020, 146 (04)
[70]   INFLUENCE OF THE DEVELOPMENT OF DIABETES-MELLITUS ON CLINICAL STATUS IN PATIENTS WITH CYSTIC-FIBROSIS [J].
LANNG, S ;
THORSTEINSSON, B ;
NERUP, J ;
KOCH, C .
EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (09) :684-687